36 Results for "

BACE-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (36)

36 Results for "BACE-IN-1" in MCE Product Catalog:

Cat. No.: HY-U00287
CAS No.: 1254166-60-3
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

BACE-IN-1 (Compound 13) is a substituted lmidazo[1 ,2-a]pyridine derivative which can inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment of diseases in which BACE is involved, such as Alzheimer's disease.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N0231
CAS No.: 28448-85-3
Synonyms: Broussochalcone B
Bavachalcone is a potent inducer of apoptosis. Bavachalcone exerts anticancer activity by promoting autophagy and apoptosis in HepG2 cells. Bavachalcone acts as an anti-neuroinflammatory and antidepressant through the NF-κB pathway. Bavachalcone inhibits osteoclasts by interfering with ERK and Akt signaling pathways and the expression of c-Fos and NFATc1. Bavachalcone exhibits a significant inhibitory effect on baculovirus-expressed BACE-1 in vitro [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-109055
CAS No.: 1388651-30-6
Purity:  99.82%
Synonyms: E2609
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

Elenbecestat (E2609) is a potent, orally bioavailable and BBB-penetrant BACE-1 inhibitor. Elenbecestat has the potential for Alzheimer's disease (AD) research [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119689
CAS No.: 1387560-01-1
Purity:  99.81%
Synonyms: CNP520
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

Umibecestat (CNP520) is a beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1) inhibitor with IC50s of 11 nM and 10 nM for human BACE-1 and mouse BACE-1, respectively [1]. Umibecestat can be used for the research of alzheimer's disease.
loading...
    loading...
Cat. No.: HY-124322
CAS No.: 1262857-73-7
Purity:  99.08%
NB-360 is a potent, brain penetrable and orally active β‐secretase 1/2 (BACE1/BACE2) dual inhibitor with IC50 values of 5 and 6 nM. NB-360 can inhibit amyloid-β protein accumulation. NB-360 can be used for the researches of inflammation and neurological disease, such as Alzheimer's disease [1] .
loading...
    loading...
Cat. No.: HY-10133
CAS No.: 797035-11-1
Purity:  99.19%
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

β-Secretase Inhibitor IV is a potent, cell-active BACE-1 inhibitor with IC50s of 15.6 and 16.3nM under BACE-1 concentrations of 2 nM and 100 pM, respectively.
loading...
    loading...
Cat. No.: HY-P4920
CAS No.: 1802078-32-5
Target:  

Fluorescent Dye

Research Areas:  

Others

Mca-SEVNLDAEFK(Dnp)-NH2 contains a highly fluorescent 7-methoxycoumarin group that is efficiently quenched by resonance energy transfer to the 2,4-dinitrophenyl group. It can be used to measure the activities of peptidases that are capable of cleaving an amide bond between the fluorescent group and the quencher group, causing an increase in fluorescence, such as can be used to measure the activity of BACE-1 .
loading...
    loading...
Cat. No.: HY-100182
CAS No.: 1310347-50-2
Purity:  98.72%
BACE1-IN-1 is an orally active, blood-brain barrier penetrant dual-target inhibitor of BACE1/2, with IC50 values of 23 nM and 24 nM against human BACE1 and BACE2, respectively. BACE1-IN-1 reduces cerebral Aβ40 levels in mice. BACE1-IN-1 can be used in studies related to Alzheimer's disease and type 2 diabetes [1] .
loading...
    loading...
Cat. No.: HY-170938
AChE-IN-82 (compound 49) is an acetylcholinesterase (AChE) inhibitor. AChE-IN-82 inhibits eeAChE, eqBChE, hMAO-A, hMAO-B, and BACE-1 with IC50s of 0.072, 9.81, 14.52, 0.024, 2.42 μM, respectively. AChE-IN-82 inhibits COX-1, COX-2 and 5-LOX with IC50s of 60.41, 0.187, 0.18 μM, respectively. AChE-IN-82 shows an excellent neuroprotective effect by significantly reducing oxidative stress induced by H2 O2 [1].
loading...
    loading...
Cat. No.: HY-126047
CAS No.: 581-49-7
Target:  

NF-κB Beta-secretase

Research Areas:  

Neurological Disease

(S)-(-)-Anatabine is an NFκB/BACE-1 inhibitor with blood-brain barrier penetration. (S)-(-)-Anatabine inhibits NFκB activation via phosphorylation of its p65 subunit. (S)-(-)-Anatabine inhibits BACE-1 transcription and reduces BACE-1 protein levels. (S)-(-)-Anatabine lowers production of Aβ1-40 and Aβ1-42 by reducing β-cleavage of amyloid precursor protein without affecting α-cleavage. (S)-(-)-Anatabine can be used for the research of Alzheimer's disease [1].
loading...
    loading...
Cat. No.: HY-P2714
CAS No.: 186142-28-9
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

SEVNLDAEFR is a substrate for BACE1 .
loading...
    loading...
Cat. No.: HY-131068
CAS No.: 2563970-92-1
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

BACE-1 inhibitor 2 is a potent and CNS permeable BACE-1 inhibitor with an IC50 of 1.5 nM in BACE-1 enzymatic assay [1].
loading...
    loading...
Cat. No.: HY-112297
CAS No.: 1262858-14-9
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

BACE-1 inhibitor 1 (Compound 8a) is a potent BACE-1 inhibitor with an IC50 of 56 nM [1].
loading...
    loading...
Cat. No.: HY-160037
CAS No.: 261349-28-4
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

SEW06622 is a BACE-1 inhibitor with an IC50 value of 6.3 μM and can be used in Alzheimer's disease research [1].
loading...
    loading...
Cat. No.: HY-P10799
Target:  

Amyloid-β

SLAFVDVLN, a molecular peptide, is a BACE-1 inhibitor with a Ki value of 94 nM. SLAFVDVLN can reduce Aβ42 production [1].
loading...
    loading...
Cat. No.: HY-163382
Cbz-Gly-Pro-Ala-O-cinnamyl (compound 25) is a small peptide targeting BACE-1 and AChE with the IC50 values of 0.02 μM and 1 μM, respectively. Cbz-Gly-Pro-Ala-O-cinnamyl shows neuroprotective effect and can be used for study of Alzheimer’s disease [1].
loading...
    loading...
Cat. No.: HY-122080
CAS No.: 616885-87-1
Memoquin is an anti-amyloid and anti-oxidant multi-target-directed ligand. Memoquin is an orally active inhibitor of BACE-1 and AChE with IC50 values of 108 and 1.55 nM, respectively. Memoquin is a cognitive enhancer that prevents the Aβ-induced neurotoxicity mediated by oxidative stress. Memoquin can be used for the research of Alzheimer’s disease (AD) [1] .
loading...
    loading...
Cat. No.: HY-129133
CAS No.: 168037-22-7
cis-Miyabenol C is an isomer of the resveratrol trimer Miyabenol C, which can be isolated from grape herbs. Miyabenol C is an inhibitor of β-amyloid (Aβ) and amyloid β precursor protein (APP) in Alzheimer's disease model mice, and inhibit β-secretase activity without changing the protein level of β-secretase BACE1 .
loading...
    loading...
Cat. No.: HY-173226
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

BACE1-IN-15 (Compound 72) is a selective inhibitor of beta-site amyloid precursor protein cleaving enzyme 1 (BACE-1) with oral activity and the ability to penetrate the blood-brain barrier. Its IC50 value is 121.65 nM (the IC50 value for BACE-2 is 480.92 nM). BACE1-IN-15 can be used in the research of the Alzheimer's disease field [1]
loading...
    loading...
Cat. No.: HY-N0231R
CAS No.: 28448-85-3
Synonyms: Broussochalcone B (Standard)
Bavachalcone (Standard) is the analytical standard of Bavachalcone. This product is intended for research and analytical applications. Bavachalcone is a potent inducer of apoptosis. Bavachalcone exerts anticancer activity by promoting autophagy and apoptosis in HepG2 cells. Bavachalcone acts as an anti-neuroinflammatory and antidepressant through the NF-κB pathway. Bavachalcone inhibits osteoclasts by interfering with ERK and Akt signaling pathways and the expression of c-Fos and NFATc1. Bavachalcone exhibits a significant inhibitory effect on baculovirus-expressed BACE-1 in vitro [1] .
loading...
    loading...